重症患者超生理动脉氧水平与死亡率的关联:多中心观察性队列研究
本研究基于英国五所大学医院ICU的回顾性队列(2014–2018年),评估高氧血症暴露与ICU死亡率的关联。多因素logistic回归显示,在0–3、0–5、0–7天暴露窗口下高氧血症与死亡率相关,但未观察到剂量反应关系。结论认为该关联不能支持因果解释,需进一步实验研究。
要点
- 高氧血症暴露与ICU死亡率在3天及以上窗口呈关联,但无剂量反应关系。
- 未发现高氧血症与呼吸诊断或机械通气存在效应修饰。
- 因果解释需谨慎,需进一步实验研究验证。
核心结论
- 在大型未选择的多中心队列中观察到高氧血症与死亡率存在关联,但缺乏剂量反应关系削弱了因果解释。
研究设计与样本
- 回顾性队列研究,纳入英国五所大学医院ICU于2014年1月31日至2018年12月31日的入院患者,数据来自NIHR Critical Care Health Informatics Collaborative。
- 采用多因素logistic回归建模高氧血症暴露与ICU死亡的关系,评估0–1、0–3、0–5、0–7天暴露窗口。
主要发现
- 0–1天窗口纳入19,515例,OR 1.15(95%CI 0.95-1.38;P=0.15)。
- 0–3天窗口纳入10,525例,OR 1.35(95%CI 1.04-1.74;P=0.02)。
- 0–5天窗口纳入6,360例,OR 1.5(95%CI 1.07-2.13;P=0.02)。
- 0–7天窗口纳入4,296例,OR 1.74(95%CI 1.11-2.72;P=0.02)。
- 未观察到剂量反应关系;无证据支持高氧血症与呼吸诊断或机械通气存在差异效应。
关键数值与推荐
- 高氧血症剂量定义为PaO2时间曲线与13.3 kPa(100 mm Hg)边界之间的面积除以潜在暴露小时数(24、72、120或168小时)。
临床怎么用
- 临床应关注重症患者动脉氧水平,避免不必要的高氧暴露,但现有证据尚不足以确立因果性临床推荐。
局限性
- 回顾性观察性设计,缺乏剂量反应关系,无法排除残余混杂,因果解释受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: There is conflicting evidence on harm related to exposure to supraphysiologic PaO2 (hyperoxemia) in critically ill patients.Objectives: To examine the association between longitudinal exposure to hyperoxemia and mortality in patients admitted to ICUs in five United Kingdom university hospitals.Methods: A retrospective cohort of ICU admissions between January 31, 2014, and December 31, 2018, from the National Institute of Health Research Critical Care Health Informatics Collaborative was studied. Multivariable logistic regression modeled death in ICU by exposure to hyperoxemia.Measurements and Main Results: Subsets with oxygen exposure windows of 0 to 1, 0 to 3, 0 to 5, and 0 to 7 days were evaluated, capturing 19,515, 10,525, 6,360, and 4,296 patients, respectively. Hyperoxemia dose was defined as the area between the PaO2 time curve and a boundary of 13.3 kPa (100 mm Hg) divided by the hours of potential exposure (24, 72, 120, or 168 h). An association was found between exposure to hyperoxemia and ICU mortality for exposure windows of 0 to 1 days (odds ratio [OR], 1.15; 95% compatibility interval [CI], 0.95-1.38; P = 0.15), 0 to 3 days (OR 1.35; 95% CI, 1.04-1.74; P = 0.02), 0 to 5 days (OR, 1.5; 95% CI, 1.07-2.13; P = 0.02), and 0 to 7 days (OR, 1.74; 95% CI, 1.11-2.72; P = 0.02). However, a dose-response relationship was not observed. There was no evidence to support a differential effect between hyperoxemia and either a respiratory diagnosis or mechanical ventilation.Conclusions: An association between hyperoxemia and mortality was observed in our large, unselected multicenter cohort. The absence of a dose-response relationship weakens causal interpretation. Further experimental research is warranted to elucidate this important question.
引用
- Palmer E, Post B, Klapaukh R, et al. The Association between Supraphysiologic Arterial Oxygen Levels and Mortality in Critically Ill Patients. A Multicenter Observational Cohort Study. Am J Respir Crit Care Med. 2019. PMID: 31513754. doi:10.1164/rccm.201904-0849OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。